These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24239907)

  • 1. Enhanced cytotoxic activity of bile acid cisplatin derivatives by conjugation with gold nanoparticles.
    Sánchez-Paradinas S; Pérez-Andrés M; Almendral-Parra MJ; Rodríguez-Fernández E; Millán A; Palacio F; Orfao A; Criado JJ; Fuentes M
    J Inorg Biochem; 2014 Feb; 131():8-11. PubMed ID: 24239907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
    Shi Y; Goodisman J; Dabrowiak JC
    Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma.
    Barbara C; Orlandi P; Bocci G; Fioravanti A; Di Paolo A; Natale G; Del Tacca M; Danesi R
    Eur J Pharmacol; 2006 Nov; 549(1-3):27-34. PubMed ID: 16978599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin.
    Brown SD; Nativo P; Smith JA; Stirling D; Edwards PR; Venugopal B; Flint DJ; Plumb JA; Graham D; Wheate NJ
    J Am Chem Soc; 2010 Apr; 132(13):4678-84. PubMed ID: 20225865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
    O'Hare A
    Nanomedicine (Lond); 2012 Jul; 7(7):947-8. PubMed ID: 23019670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval?
    Craig GE; Brown SD; Lamprou DA; Graham D; Wheate NJ
    Inorg Chem; 2012 Mar; 51(6):3490-7. PubMed ID: 22390791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H; Cheng Q; Yuan S; Ding X; Liu Y
    Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.
    Wang X; Guo Z
    Dalton Trans; 2008 Mar; (12):1521-32. PubMed ID: 18335133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.
    Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
    J Inorg Biochem; 2014 Nov; 140():72-9. PubMed ID: 25063910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel.
    de Oliveira R; Zhao P; Li N; de Santa Maria LC; Vergnaud J; Ruiz J; Astruc D; Barratt G
    Int J Pharm; 2013 Oct; 454(2):703-11. PubMed ID: 23701998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating the drug resistance of cisplatin using a platinum prodrug based delivery system.
    Min Y; Mao CQ; Chen S; Ma G; Wang J; Liu Y
    Angew Chem Int Ed Engl; 2012 Jul; 51(27):6742-7. PubMed ID: 22639083
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment.
    Kumar A; Huo S; Zhang X; Liu J; Tan A; Li S; Jin S; Xue X; Zhao Y; Ji T; Han L; Liu H; Zhang X; Zhang J; Zou G; Wang T; Tang S; Liang XJ
    ACS Nano; 2014 May; 8(5):4205-20. PubMed ID: 24730557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.
    Ravera M; Perin E; Gabano E; Zanellato I; Panzarasa G; Sparnacci K; Laus M; Osella D
    J Inorg Biochem; 2015 Oct; 151():132-42. PubMed ID: 26277416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold nanoconjugates reinforce the potency of conjugated cisplatin and doxorubicin.
    Iram S; Zahera M; Khan S; Khan I; Syed A; Ansary AA; Ameen F; Shair OHM; Khan MS
    Colloids Surf B Biointerfaces; 2017 Dec; 160():254-264. PubMed ID: 28942160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum (IV) pro-drug conjugated NaYF4 :Yb(3+) /Er(3+) nanoparticles for targeted drug delivery and up-conversion cell imaging.
    Dai Y; Kang X; Yang D; Li X; Zhang X; Li C; Hou Z; Cheng Z; Ma P; Lin J
    Adv Healthc Mater; 2013 Apr; 2(4):562-7. PubMed ID: 23184494
    [No Abstract]   [Full Text] [Related]  

  • 19. Beyond platinums: gold complexes as anticancer agents.
    Nardon C; Boscutti G; Fregona D
    Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticulate platinum(II) anticancer drug: synthesis and characterization of amphiphilic cyclotriphosphazene-platinum(II) conjugates.
    Yu JY; Jun YJ; Jang SH; Lee HJ; Sohn YS
    J Inorg Biochem; 2007 Nov; 101(11-12):1931-6. PubMed ID: 17709142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.